Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2003
10/30/2003US20030203869 Expression vectors for stimulating an immune response and methods of using the same
10/30/2003US20030203868 Inhibition of pathogen replication by RNA interference
10/30/2003US20030203866 Olfactory g-protein coupled coupled receptors; blot analysis; polymerase chain reactions; animal models
10/30/2003US20030203864 Treatment of cancer
10/30/2003US20030203863 Interleukins (IL-2); cytokines; bovine growth hormone; cytomegalovirus; gene therapy
10/30/2003US20030203862 An antisense compound 8 to 30 nucleobases targeted to 5' untranslated region, coding region, intron:exon junctin, intron region, exon region, translation termination codon region or 3' untranslated region of nucleic acid molecule
10/30/2003US20030203853 Trifluoromethylketone derivatives containing amide groups used as human leukocyte elastase inhibitor and treats dermal aging
10/30/2003US20030203852 Acyl pseudodipeptides which carry a functionalised auxialiary arm
10/30/2003US20030203851 Substituted oxadiazole, peptoids which are useful for treating adult respiratory distress syndrome, septic shock and myocardial ischemia-reperfusion injury
10/30/2003US20030203850 Transdifferentiation of pancreatic acinar cells
10/30/2003US20030203849 Composition promoting lacrimal secretion
10/30/2003US20030203848 Peptaibol antibiotics, synthesized from Acremonium tubakii, during fermentation and released into culture medium, containing high content of beta-aminobutyric acid and isovaline
10/30/2003US20030203847 Methods and compositions in treating pain and painful disorders using 9949, 14230, 760, 62553, 12216, 17719, 41897, 47174, 33408, 10002, 16209, 314, 636, 27410, 33260, 619, 15985, 69112, 2158, 224, 615, 44373, 95431, 22245, 2387, 16658, 55054, 16314, 1613, 1675, 9569 or 13424 molecules
10/30/2003US20030203845 Useful for treating bleeding, reducing clotting time, enhancing haemostasis, reducing the number of administrations of coagulation factor protein needed to accomplish haemostasis, prolonging clot lysis time
10/30/2003US20030203844 Administering platelet derived growth factor, endothelial growth factor or a combination to modulate neural stem cell or neural porgenitor cell activity in vivo to a patient suffering from nerveous system disorder or disease
10/30/2003US20030203842 Apolipoprotein A-l agonists and their use to treat dyslipidemic disorders
10/30/2003US20030203841 T20/DP178 and T21/DP107 are activators of human phagocyte formyl peptide receptors
10/30/2003US20030203840 Nucleic acid containing at least one adenine base, a guanine base, a cytosine base, and at least thymin or uracil base and nucleic acid is atleast 12 bases in length, hybridizes to sense or antisense strand of second nucleic acid
10/30/2003US20030203839 Iron binding protein lactoferrin as a medicament to prevent the progression of systemic inflammatory response syndrome (SIRS) into sepsis, septic shock and multiple organ failure in mammal
10/30/2003US20030203838 Compositions and methods for inhibiting angiogenesis
10/30/2003US20030203837 IG/OB fusions and uses thereof
10/30/2003US20030203836 Methods for reduced renal uptake of protein conjugates
10/30/2003US20030203835 Screening for inotropic agents using fluorescence, absorption spectra, luminescence or radioactivity
10/30/2003US20030203834 Angiotensin-(1-7) and angiotensin-(1-7) agonists for inhibition of cancer cell growth
10/30/2003US20030203487 Using circular nucleic acid integration vector, restriction enzymes and transposase to transfer and insert preferential nucleotide sequences into target genome
10/30/2003US20030203482 Stimulation of cellular regeneration and differentiation tn the inner ear
10/30/2003US20030203464 Comprise Gtpase (RAC-GEF) polypeptide for treating diagnosis and treatment of cell proliferative disorders; antiproliferative agents
10/30/2003US20030203463 Nucleotide sequence which encodes a flavin monooxygenase, the corresponding protein and their uses in the spheres of diagnosis and therapy
10/30/2003US20030203462 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/30/2003US20030203452 Human chemokine beta-13
10/30/2003US20030203450 STRL33, a human fusion accessory factor associated with HIV infection
10/30/2003US20030203444 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/30/2003US20030203442 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/30/2003US20030203440 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptide; cancer diagnosis
10/30/2003US20030203439 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/30/2003US20030203437 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/30/2003US20030203436 Nucleotide sequences coding membrane protein for use as antiproliferative/antitumor/antiinflammatory/anticarcinogenic agents
10/30/2003US20030203435 Nucleotide sequences coding membrane protein for use as antiproliferative/antitumor/antiinflammatory/anticarcinogenic agents
10/30/2003US20030203434 Nucleotide sequences coding membrane protein for use as antiproliferative/antitumor/antiinflammatory/anticarcinogenic agents
10/30/2003US20030203433 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/30/2003US20030203432 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptide; cancer diagnosis
10/30/2003US20030203431 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/30/2003US20030203430 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/30/2003US20030203429 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/30/2003US20030203428 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptide; cancer diagnosis
10/30/2003US20030203426 Comprises proteins for diagnosis, treatment and prevention of arthritis, muscular, cancer, nervous system, sex and urogenital disorders
10/30/2003US20030203414 Enzyme inhibitor for treating and preventing cancer, apoptosis defects and viral infections
10/30/2003US20030203409 Comprises monoclonal antibody for detection, diagnosis and treatment of cell proliferation disorders
10/30/2003US20030203406 Human methionine aminopeptidase type 3
10/30/2003US20030203403 Time-resolved fluorescence assay for the detection of multimeric forms of A-beta 1-40
10/30/2003US20030203402 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/30/2003US20030203401 Comprises nucleotide sequences coding membrane protein for diagnosing, preventing and treating cell proliferative, inflammatory or tumor disorders
10/30/2003US20030203396 Human galactosyltransferases
10/30/2003US20030203383 Novel neurotrophic factor immunoassays
10/30/2003US20030203380 Gene linked to osteoarthritis
10/30/2003US20030203377 Complementary DNAs encoding proteins with signal peptides
10/30/2003US20030203373 Method for identifying a pharmacologically active substance
10/30/2003US20030203372 Analysis method
10/30/2003US20030203363 Novel human proteins, polynucleotides encoding them and methods of using the same
10/30/2003US20030203361 13 human colon and colon cancer associated proteins
10/30/2003US20030203356 RNase L activator-antisense complexes
10/30/2003US20030203052 Superoxide dismutase-containing cucumber extract coated and/or microencapsulated in a fat-soluble agent based on a fatty substance can be used by the topical or oral route; antiallergens; sunscreen agents; foods; drugs; cosmetics
10/30/2003US20030203051 Plant extracts for the treatment of increased bone resorption
10/30/2003US20030203045 Therapeutic composition for the treatment of HIV-1 and HIV-2
10/30/2003US20030203040 Controlled release microencapsulated NGF formulation
10/30/2003US20030203032 Dilute aqueous solution containing epidermal growth factor in gel
10/30/2003US20030203014 Positioning solid support into injury; wound healing agents; peptide
10/30/2003US20030203006 Immunomodulator
10/30/2003US20030203003 Drug releasing biodegradable fiber implant
10/30/2003US20030203001 Drug delivery; analgesics, antiinflammatory agents; contacting skin with hydrogel containing drugs
10/30/2003US20030202991 Delivery of biologically active polypeptides
10/30/2003US20030202990 Diffusion of brain, blood barrier
10/30/2003US20030202989 Use of toxin peptides and/or affinity handles for delivering compounds into cells
10/30/2003US20030202980 Methods and reagents for decreasing clinical reaction to allergy
10/30/2003US20030202976 Methods and reagents for diagnosis and treatment of diabetes
10/30/2003US20030202974 Agents for the prevention of organ damage induced by therapeutic agents
10/30/2003US20030202971 Genetic engineering; binding polypeptide to antibody ; screening, modulation, calibration
10/30/2003US20030202970 Carboxymethylcellulose sponges, membranes, gels, particles; anticoagualnts, drug delivery
10/30/2003US20030202968 Diacylglycerol O-Acyltransferase 2a (DGAT2ALPHa)
10/30/2003US20030202967 Diabetic therapy
10/30/2003US20030202966 Isolated stromal cells and methods of using the same
10/30/2003US20030202963 Method of treating cancer
10/30/2003US20030202962 Antigen encoded nucleic acids; controlling cell differentiation, cell proliferation; transcription factor controller
10/30/2003US20030202961 Methods of therapy for HIV infection
10/30/2003US20030202960 Therapeutic angiogenic factors and methods for their use
10/30/2003US20030202958 Dialysis solution including polyglycol osmotic agent
10/30/2003US20030202939 Forming oxygen free radicals; destroying tumor, cancer
10/30/2003EP1496982A2 Solid forms of salts with tyrosine kinase activity
10/30/2003CA2785889A1 Peptide inhibitors of protein kinase c
10/30/2003CA2492655A1 Peptides capable of inducing attraction to the axonal growth and their use for treating neurodegenerative diseases
10/30/2003CA2483476A1 Fusion polypeptides and methods for inhibiting microbial adhesion
10/30/2003CA2483327A1 Oligonucleotides from coding sequences for the surface component of ptlvenvelope proteins and uses thereof
10/30/2003CA2482924A1 Adjuvant enhanced immunotherapy
10/30/2003CA2482919A1 Compositions and methods relating to endothelial cell signaling using the protease activated receptor (par1)
10/30/2003CA2482907A1 Tissue specific genes and gene clusters
10/30/2003CA2482764A1 Cell wall mannoproteins and active epitopes from candida albicans and antibodies recognizing them
10/30/2003CA2482719A1 Conjugates of membrane translocating agents and pharmaceutically active agents
10/30/2003CA2482714A1 Indane acetic acid derivatives and their use as pharmaceutical agents
10/30/2003CA2482589A1 Compositions and method of treating alzheimer's disease
10/30/2003CA2482508A1 Combination therapy for the treatment of cancer
1 ... 1742 1743 1744 1745 1746 1747 1748 1749 1750 1751 1752 1753 1754 1755 1756 1757 1758 1759 1760 1761 1762 ... 3163